NCT05322460

Brief Summary

The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. Some of these LS-BC return to daily life without any problems; however, in many cases, they experience and have to deal with physical sequelae (chronic fatigue, pain, etc.) psychological sequelae (anxiety, depression, fear of recurrence, etc.) and social sequelae (altered interpersonal relationships, difficulty in returning to work, etc.). For many LS-BC, these health problems are not being met by health professionals. Thus there is a need to promote greater continuity and coordination between specialized oncology care and primary health care in order to enhance specific follow-up of these women in the community. However, the role of the primary health care team in the provision of care in the long-term cancer survival is not clearly defined and few actions have been aimed at improving care activities, standardizing procedures and protocols, developing documentation and registries and updating the training of health care professionals. Therefore, this study aim to design, implement, and evaluate a web based tailored intervention, using artificial intelligence, to improve the quality of life of long-term breast cancer survivors, and self-efficacy for the management of late sequelae from primary care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
1.7 years until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

1.8 years

First QC Date

March 28, 2022

Last Update Submit

September 24, 2025

Conditions

Keywords

Cancer survivorsLong-Term Cancer SurvivorsLong Term Cancer SurvivorsSurvivorship

Outcome Measures

Primary Outcomes (3)

  • Quality of life Cancer Survivor (QOL-CS)

    The QOL-CS, Spanish version (Ferrell B, Hassey-Dow K, Grant M. Quality of Life Patient/Cancer Survivor Version (QOL-CS) \[Internet\]. Measurement Instrument Database for the Social Science. 2012). Scale specific for cancer survivor. Likert-type scale with 10 options (1 extremely poor and 10 excellent) with 41 items that measure the four domains of quality of life: physical, psychological, social and spiritual well-being.

    Changes from baseline, 3-months, 6 months, and 9 month

  • Self-Efficacy for Managing Chronic Disease

    The Self-Efficacy for Managing Chronic Disease- 6-Item Scale (SEMCD-6) (Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014; 67(11): 1265-73). The scale is structured in 6 items related to symptom control, role performance, emotional state and communication with health professionals

    Changes from baseline, 3-months, 6 months, and 9 month

  • Sociodemographic data of LS-BC

    Sociodemographic data of the LS-BC (age, sex, marital status, educational level, employment status) will be collected by means of an ad hoc questionnaire at the beginning of the intervention.

    Baseline

Secondary Outcomes (1)

  • Client Satisfaction Questionnaire (CSQ-8)

    4 weeks

Study Arms (2)

Intervention group

EXPERIMENTAL

The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs

Other: CUMACA-M Program

Control group

NO INTERVENTION

Usual care in the nursing consultation in primary care

Interventions

The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs

Intervention group

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • having been diagnosed with breast cancer
  • having completed active oncological treatments (chemotherapy and/or radiotherapy) in a period of time greater than five years,
  • be free of disease at the time of data collection
  • be a woman and over 18 years of age
  • have knowledge of Internet use.

You may not qualify if:

  • Women with a diagnosis of cancer other than breast cancer
  • Recurrence of cancer or metastasis that causes a new treatment
  • Being in active treatment for recurrence or new cancer
  • Being a man

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Public University of Navarre

Pamplona, 31008, Spain

RECRUITING

Related Publications (1)

  • Pimentel-Parra GA, Soto-Ruiz N, Escalada-Hernandez P, San Martin-Rodriguez L, Garcia-Vivar C. EHealth intervention for quality of life in long-term breast cancer survivors: Randomized controlled trial. J Natl Cancer Inst. 2026 Jan 24:djag020. doi: 10.1093/jnci/djag020. Online ahead of print.

Study Officials

  • Cristina Garcia Vivar, PhD

    Universidad Pública de Navarra

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cristina García-Vivar, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 28, 2022

First Posted

April 11, 2022

Study Start

December 15, 2023

Primary Completion

September 30, 2025

Study Completion

November 1, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations